Valeant Urges Fed. Circ. To Revive Lawsuit Over Jublia
Valeant Pharmaceuticals is asking the Federal Circuit to revive a lawsuit accusing Mylan of infringing its patents covering the antifungal medication Jublia, saying that seeking approval to sell a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article